General form of registration statement for all companies including face-amount certificate companies

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.10.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 6 Months Ended 12 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Dec. 31, 2017
Dec. 31, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net loss $ (2,223,333) $ (27,031,599) $ (29,705,669) $ (5,903,982)
Adjustments to reconcile net loss to cash flows used in operating activities:        
Depreciation and amortization 4,748 16,854 33,888 30,248
Bad debt expense 12,250 25,750 59,750
Termination of licensing agreement     132,804
Non cash interest 9,363,244 9,363,244 66,874
Amortization of debt discount 759,587 710,658 1,461,054 748,840
Common stock issued in connection with loan extension     17,970
Stock based compensation 605,210 355,979 830,788 582,348
Gain on settlement of debt (285,924) (296,592)
Change in fair value of option modifications     53,858
Change in fair value of derivative liabilities 15,897,993 15,962,822 2,673,948
Changes in operating assets and liabilities:        
Accounts receivable (18,300) (51,750) (55,700) (32,000)
Prepaid expenses and other current assets 12,071 1,466 (4,810) (5,996)
Security deposit     4,212 (12,300)
Accounts payable and accrued expenses 25,696 (89,040) 548,189 (42,740)
Settlement payable (15,000) (270,000) (300,000) 65,000
Deferred revenue (117,698) (277,521) (407,571) (434,022)
Net cash used in operating activities (954,769) (1,659,640) (2,540,395) (1,999,400)
CASH FLOWS FROM INVESTING ACTIVITIES:        
Purchase of equipment (29,563) (2,970) (22,594)
Payment for intellectual property     (305,647)
Net cash used in investing activities (29,563) (2,970) (328,241)
CASH FLOWS FROM FINANCING ACTIVITIES:        
Proceeds from sale of common stock 150,000 940,000 940,000 100,000
Proceeds from common stock subscriptions 1,150,000    
Proceeds from notes payable 250,000    
Proceeds from convertible notes payable 1,660,000 1,660,000 2,714,448
Repayments of notes payable (187,748) (187,748) (564,412)
Net cash provided by financing activities 1,550,000 2,412,252 2,412,252 2,250,036
Net decrease in cash and restricted cash 565,668 752,612 (131,113) (77,605)
Cash and restricted cash, beginning of the year 11,342 92,455 92,455 220,060
Cash and restricted cash, end of year 577,010 845,067 11,342 92,455
Supplemental disclosures of cash flow information:        
Interest paid 10,507 10,507 106,333
Taxes paid
Non cash financing activities:        
Reclassify fair value of debt derivative at payoff of note payable     262,271
Common stock issued in settlement of related party accounts payable     80,433
Common stock issued in connection with issuance of convertible notes payable     30,000
Reclassify fair value of debt derivative at note modification 30,806,073 30,806,073
Common stock issued in settlement of convertible notes payable     $ 220,000
Common stock issued in connection with issuance of notes payable 25,500 220,000    
Reclassify fair value of warrant liability upon adoption of ASC 2017-11 $ 175,975